A comprehensive review published in Nano Research reveals how mechanical forces—such as fluid shear, matrix stiffness, and cyclic strain—are essential for building realistic organoids and organ-on-a-chip models. The work bridges mechanobiology and microengineering, offering a roadmap for designing next-generation in vitro systems that truly mimic human physiology. These advances could revolutionize drug screening, disease modeling, and personalized medicine.

The Vaccine Innovation Center at Korea University College of Medicine has been selected by the Korea Disease Control and Prevention Agency (KDCA) as the lead institution for a national hantavirus vaccine development project.

The initiative is part of the Korean government’s strategic efforts to establish a rapid-response vaccine development system capable of producing vaccine prototypes within 200 days of the emergence of a future pandemic. The Center will oversee the overall project, working in collaboration with biotechnology companies.

Hiroshima University researchers have demonstrated a proof of concept for the mass-production of genome-edited T cells that can be used to treat malignant tumors, using a genetic engineering technique called Platinum TALEN.

A team of researchers reports the creation of an AI test that predicts the risk of breast cancer recurrence—one that does so more quickly and more inexpensively than current methods, which involve genomic testing.